Researchers from the European Centre for Allergy Research Foundation (ECARF) and the Institute of Allergology at Charité Universitätsmedizin Berlin have conducted clinical trials on Respiray Wear A+, revealing that the wearable allergy relief device reduced the symptoms of pollen, dust mite and cat allergies more effectively than most anti-allergy medications or allergen-specific immunotherapy.
Full Article
THURSDAY, May 9, 2024 (HealthDay News) -- Every cold and flu season, folks are flooded with ads for zinc lozenges, sprays and syrups that promise to shorten their sniffles.
Zinc might indeed reduce the duration of common cold symptoms by about two days, a new evidence review says.